fda banning compounded tirzepatide Lilly's weight-loss drug removed from FDA's shortage list FDA moves to remove GLP-1

The FDA has issued warnings about unapproved GLP-1 drugs

Nothing here is medical advice, and individual responses vary

Your clinician helps you choose based on your preferences and history, and you can discuss switching at any follow-up

Optimizes Overall Health Sermorelin therapy addresses multiple aspects of health, including energy, recovery, and cognitive performance, making it a holistic approach to improving wellness

The FDA investigation is not the first time an association between suicidal ideation and GLP-1 medications has been reviewed

Very strange. Human Studies on GLP-1 and Addiction A number of retrospective and pilot RCT trials on GLP-1s and substance use have been published or announced, with many more on the way